Alpha Cognition Inc. Interest Expense Nonoperating
Alpha Cognition Inc. (ACOG) reported Interest Expense Nonoperating of -$644 for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2025-08-14
- Alpha Cognition Inc. interest expense nonoperating for the quarter ending 2025-06-30 was -$644.00, a 104.23% decline year-over-year.
- Alpha Cognition Inc. interest expense nonoperating for the quarter ending 2025-03-31 was $8.81K, a 6.65% increase year-over-year.
- Alpha Cognition Inc. interest expense nonoperating for the quarter ending 2024-12-31 was $63.12K, a 1703.94% increase year-over-year.
- Alpha Cognition Inc. interest expense nonoperating for the quarter ending 2024-09-30 was $18.68K, a 94.43% increase year-over-year.
- Alpha Cognition Inc. interest expense nonoperating for fiscal 2024 was $105.27K, a 501.01% increase from fiscal 2023.
- Alpha Cognition Inc. interest expense nonoperating for fiscal 2023 was $17.52K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$644.00 10-Q · filed 2025-08-14 | $8.16K 10-Q · filed 2025-08-14 | $71.28K derived: sum of 3 quarters · filed 2025-08-14 | $89.96K derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | $8.81K 10-Q · filed 2025-05-15 | $71.93K derived: sum of 2 quarters · filed 2025-05-15 | $90.61K derived: sum of 3 quarters · filed 2025-05-15 | $105.82K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-12-31 | $63.12K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $81.80K derived: sum of 2 quarters · filed 2025-03-31 | $97.02K derived: sum of 3 quarters · filed 2025-08-14 | $105.27K 10-K · filed 2025-03-31 |
| 2024-09-30 | $18.68K 10-Q · filed 2024-11-14 | $33.90K derived: sum of 2 quarters · filed 2025-08-14 | $42.15K 10-Q · filed 2024-11-14 | $45.65K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-06-30 | $15.22K 10-Q · filed 2025-08-14 | $23.47K 10-Q · filed 2025-08-14 | $26.97K derived: sum of 3 quarters · filed 2025-08-14 | $36.58K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $8.26K 10-Q · filed 2025-05-15 | $11.76K derived: sum of 2 quarters · filed 2025-05-15 | $21.36K derived: sum of 3 quarters · filed 2025-05-15 | $22.90K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $3.50K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $13.11K derived: sum of 2 quarters · filed 2025-03-31 | $14.64K derived: sum of 3 quarters · filed 2025-03-31 | $17.52K 10-K · filed 2025-03-31 |
| 2023-09-30 | $9.61K 10-Q · filed 2024-11-14 | $11.14K derived: sum of 2 quarters · filed 2024-11-14 | $14.02K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $1.53K 10-Q · filed 2024-08-12 | $4.41K 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |